Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis. Azzopardi L, Thompson SAJ, Harding KE, Cossburn M, Robertson N, Compston A, Coles AJ, Jones JL J Neurol Neurosurg Psychiatry. 2013 Dec 24. PMID: 24368840. Abstract CommentRecommendBookmarkWatch